![[Sidebar]](images/mast02.gif)
|
Research Projects funded between November 1, 2001 and January 31, 2002
General
Arden WA, Gross DR. Governor’s Venture Technology, $80,000, Common Molecular Pathways of Protection Against Ischemia-Reperfusion Injury
Clarkson RB. Governor’s Venture Technology, $30,000, Magnetic Resonance Research Opportunities in Veterinary Medicine
Cooke PS. United Soybean Board, $10,000, Genistein Induces Thymic Atrophy: A Potential Human Health Risk (SHRP application)
Cooke PS. Governor’s Venture Technology, $23,000, Molecular Mechanism of Genistein-Induced Thymic Atrophy
Cope R. American Cancer Society, $45,907, Do PCBs Enhance UV Radiation-Induced Skin Cancer?
McAllister MM. Governor’s Venture Technology, $10,000, Using Plasmodium Falciparum Sporozoites Produced in Vitro to Infect Human Hepatocytes: an Untried Approach Towards Vaccine Development
Moreno SN. National Institutes of Health, $229,500, The Role of Phospholipace C in Trypanosoma cruzi.
Goetz TE. Houston Equine Research Organization, $20,000, Airway Inflammatory Mediators and Exercise-Induced Arterial Hypoxemia in Strenuously Exercising Thoroughbred Horses
Martin T, Morin DE. Morris Animal Foundation, $7,500, Pharmacokinetics and Safety Profiles of Flunixin Meglumine and Ketoprofen in Llamas
Bagchi IC. Governor’s Venture Technology, $25,000, The Role of Lipid Mediators in Embryo Implantation
Bunick D. Governor’s Venture Technology, $35,000, Conditional Knockout of the Mouse Androgen Receptor Gene
Cope R. Campus Research Board, $20,000, Does Ultraviolet Radiation (UV) Exposure Delay the Healing of Buruli Ulcers?
Heine P. Campus Research Board, $9,875, Estrogen’s Probable Anti-Obesity Mechanism
Hess RA. Governor’s Venture Technology, $18,000, Development of Immortalized Cell Lines for the Study of Endocrine Disruptors in Male Reproduction, Mice
Schantz SL. Governor’s Venture Technology, $21,000, Delayed Neurotoxicity Following Perinatal PCB and MEHG Exposure, Rats
Tischkau S. Governor’s Venture Technology, $25,000, Circadian Control of Gonadtropin Releasing Hormone, Mice
Angus JC. Companion Animal Memorial Fund (CAMF), $3,940, Evaluation of Aerobic and Anaerobic Microbial Flora and Antimicrobial Susceptibility Patterns of Isolates from the Horizontal Ear Canal and Tympanic Cavity of Dogs Requiring Total Ear Canal Ablations
Ehrhart N. Governor’s Venture Technology, $24,000, The Effect of Sustained Release TGF-beta on Healing in Preoperatively Irradiated Bone
Ehrhart N. Governor’s Venture Technology, $60,000, Effect of Irradiation on Differentiation and Growth Factor Expression During Bone Transport
Fan TM. Governor’s Venture Technology, $12,000, Investigating Alpha-Chymase Expression in Canine Mast Cell Tumors
Hess RA. Governor’s Venture Technology, $36,000, Contraception in Male Feral Dogs and Cats
Kitchell BE. Governor’s Venture Technology, $90,000, Bioresorbable Nanohybrid Materials for Drug and Gene Delivery
McCullough, SM. CAMF, $2,950, Clinical Assessment of Acid-Base Status in Cats: Calculation of Plasma Atot and Ka Values for use in the Strong Ion Approach to Acid-Base Balance
Oyama MA. Governor’s Venture Technology, $35,000, Characterization of Cardiac Troponin I and T in Animals With Cardiac Disease, Feline
Prosek R. CAMF, $3,650, Plasma Neurohormone Levels in Assessment of Acute Dyspnea in Dogs
Roberts J. CAMF, $6,000, The Use of a Hemoblobin-Based Oxygen Carrier for Measurement of Circulating Blood Volume in the Dog
Tripathy DN. Morris Animal Foundation, $20,000, Characterization of Pox Viruses of Hawaiian Endangered Wild Birds
Valli VE. Governor’s Venture Technology, $60,000, Molecular Pathology: The Characterization of Specific Neoplastic Lesions in Animals by Cellular, Subcellular and Molecular Techniques
Vimr ER. Governor’s Venture Technology, $35,000, Pasteurella Multocida Sialylation and the Host-Pathogen Interaction
Haschek-Hock WM. International Life Sciences Institute, $50,000, Fumonisin-induced Cardiovascular and Atherosclerotic Disease
Scherba G. U.S. Department of Agriculture, $180,000, Use of cytokines as molecular adjuvants to modulate alphaherpesvirus infection
Zuckermann FA. Governor’s Venture Technology, $25,000, Role of Interferon-a on the Development of Immunity to Porcine Reproductive and Respiratory Syndrome Virus